Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Cash from Financing Activities came in at $345033.0 in Q2 2026, down 95.81% on a YoY basis from $8.2 million in Q2 2025, and down 43.4% quarter-over-quarter from $609622.0 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Cash from Financing Activities for 16 consecutive years, with $345033.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 95.81% year-over-year to $345033.0; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (down 88.87% YoY), and the FY2025 full-year result was $8.0 million, up 10.45% from the prior year.
- Cash from Financing Activities retreated to $345033.0 in Q2 2026 per NMTC's latest filing, from $609622.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $8.2 million in Q2 2025 and bottomed at -$509325.0 in Q4 2024.
- Historically, Cash from Financing Activities has averaged $1.5 million across 5 years, with a median of $635791.5 in 2023.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 205677.95% in 2023, then plunged 142.27% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$15713.0 in 2022, then soared by 7768.9% to $1.2 million in 2023, then sank by 142.27% to -$509325.0 in 2024, then jumped by 129.02% to $147823.0 in 2025, then jumped by 133.41% to $345033.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $345033.0, $609622.0, and $147823.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | 345,033.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 345,033.00 |
| Mar 31, 2026 | 609,622.00 |
| Dec 31, 2025 | 147,823.00 |
| Sep 30, 2025 | 66,978.00 |
| Jun 30, 2025 | 8.23 Mn |
| Mar 31, 2025 | 245,216.00 |
| Dec 31, 2024 | -509,325.00 |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 661,961.00 |
| Dec 31, 2022 | -15,713.00 |
| Mar 31, 2022 | -322.00 |
| Dec 31, 2021 | 12.02 Mn |
| Sep 30, 2021 | -24,980.00 |
| Jun 30, 2021 | 35,885.00 |
| Mar 31, 2021 | 6.53 Mn |